ArticleBritish journal of clinical pharmacology2019

Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population-based cohort study.

Kristian B Filion et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.